Skip to content

Industry Event

DIA Global 2023

The DIA 2023 Global Annual Meeting invites industry, regulatory government, academics, and patients to network, problem-solve, and discuss global and local challenges facing the life sciences community. Hosted in Boston, DIA 2023 will amplify different perspectives while highlighting expertise across the globe to reimagine current processes that better enhance health and well-being.

Join TransCelerate at the following sessions:

  • Monday, 26 June 10:45 a.m.: “Using Benchmark Data to Identify Intelligent Automation Implementation & Opportunity Trends within the ICSR Process” with Neal Grabowski, Head Signal Management (Sanofi)
  • Tuesday, 27 June 1:15 p.m.: “Meta-Collaboration to Improve Decentralized Trial Excellence: Updates from the Collaboration Landscape” with Rob DiCicco, Vice President, Portfolio Management (TransCelerate BioPharma)
  • Tuesday, 27 June 4:00 p.m.: “Negotiating Your Way through the Vigilance Agreement Maze-Is There A Better Way?” with Yvonne Gibble, Executive Director Pharmacovigilance Licensing & Business Development (Merck)
  • Wednesday, 28 June 8:30 a.m.: “Real-World Data Quality: Components and Considerations of Data Sources Used for Regulatory Decision-Making” with Abigail Seifert, Global Head GCP & PV Country Quality (Novartis)
  • Wednesday, 28 June 8:30 a.m.: “Returning Individual Participant Data: A Cultural & Operational Shift towards Personalized Clinical Trial Options” with Jean Sposaro, Director, Global Business Lead-Industry Collaborations (BMS)
  • Wednesday, 28 June 8:30 a.m.: “Current Practice and Opportunities for Rapid Use of Real-World Data in Safety Signal Assessment” with Vaishali Patadia, Head of Signal Management & Risk Management in Global Patient Safety (Amgen)
  • Wednesday, 28 June 1:15 p.m.: “Regulatory Insights into Decentralized Trials” with Janice Chang, CEO (TransCelerate BioPharma)
  • Wednesday, 28 June 1:15 p.m.: “Real-World Data Standards and Protocol Designs for Information Exchange and Data Flow” with Bill Illis, Global Head, Collaboration & Technology Strategy, Clinical Development & Analytics (Novartis)
  • Thursday, 29 June 8:30 a.m.: “Developing an Attitude of Gratitude: The Importance of Showing Gratitude in Our Clinical Trial Participants throughout the Clinical Trial Journey” with Pete Schaeffer, Digital & Process Optimization Leader (GSK)